Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
Clinical trial NCT04592952 · UNKNOWN
Trial details
- NCT number
- NCT04592952
- Sponsor
- Danish Headache Center
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-08
- Primary completion
- 2025-08-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.